BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented

    PMA: P030027 · Supplement: S002 · Decision Jun 23, 2006
    View on FDA
    Classifications
    1
    FEI Numbers
    34
    Registration Numbers
    34

    Basic Information

    Device Name
    Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented
    Trade Name
    CERAMIC TRANSCEND ARTICULATION SYSTEM
    PMA Number
    P030027
    Supplement Number
    S002
    Device Class
    FDA Class 3
    Product Code
    MRA
    Generic Name
    Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented
    Medical Specialty
    Unknown
    Advisory Committee
    Orthopedic
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    June 23, 2006
    Date Received
    March 8, 2006
    Supplement Type
    Real-Time Process
    Supplement Reason
    Change Design/Components/Specifications/Material
    Expedited Review
    N

    Advisory Committee Statement

    APPROVAL FOR THE ADDITION OF AN INTERMEDIATE CERAMIC LINER SIZE (36/48G); THREE REPLACEMENT 36MM OD CERAMIC HEADS WITH CONSISTENT OFFSET (-3.5 MM, 0 MM, AND +3.5 MM); AND FEMORAL STEMS AND ACETABULAR SHELLS AS SPECIFIED IN SUBMISSIONS RECEIVED MARCH 8, 2006 AND JUNE 21, 2006 WHICH HAVE BEEN ROUND SUBSTANTIALLY EQUIVALENT VIA THE 510(K) PROCESS. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME CERAMIC LINEAGE/ TRANSCEND ARTICULATION SYSTEM AND IS INDICATED FOR USE IN PRIMARY TOTAL HIP ARTHROPLASTY IN SKELETALLY MATURE PATIENTS WITH NON-INFLAMMATORY DEGENERATIVE JOINT DISEASE SUCH AS OSTEOARTHRITIS, AVASCULAR NECROSIS, CONGENITAL HIP DYSPLASIA, AND TRAUMATIC ARTHRITIS.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    MRA Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented